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 Abstract  — Virtual  reality  (VR)  techniques  to  understand 
and obtain conclusions of data in an easy way are being used by 
the  scientific  community.  However,  these  techniques  are  not 
used  frequently  for  analyzing  large  amounts  of  data  in  life 
sciences, particularly in genomics, due to the high complexity of 
data  (curse  of  dimensionality).  Nevertheless,  new  approaches 
that allow to bring out the real important data characteristics, 
arise  the  possibility  of  constructing  VR  spaces  to  visually 
understand the intrinsic  nature of  data.  It  is  well  known the 
benefits of representing high dimensional data in tridimensional 
spaces  by  means  of  dimensionality  reduction  and 
transformation  techniques,  complemented  with  a  strong 
component of  interaction methods.  Thus,  a novel  framework, 
designed for helping to visualize and interact with data about 
diseases, is presented. In this paper, the framework is applied to 
the Van‘t Veer breast cancer dataset is used, while oncologists 
from  La  Paz  Hospital  (Madrid)  are  interacting  with  the 
obtained results.  That is  to  say a first  attempt to generate a 
visually  tangible  model  of  breast  cancer  disease  in  order  to 
support the experience of oncologists is presented.
Keywords:  dimensionality  reduction,  visualization,  bio-
informatics,  manifold  learning,  virtual  reality  spaces,  cancer 
classification,  visual  data  mining,  genetic  algorithms,  similarity 
structure preservation, genomics.
I. INTRODUCTION
Nowadays,  around  60  people  die  of  diseases  such  as 
cancer every minute. The value is even more concerning if 
instead of thinking in minutes, we do it in hours or days. It is, 
therefore,  a  problem  of  high  social  impact  that  must  be 
solved as  quickly as possible.  Finding a cure for  diseases 
such  as  cancer  would  translate  into  a  much  higher  life 
expectancy.  In  the  scientific  field,  expert  biologists  are 
devoted to the study of possible solutions to these kinds of 
diseases. Among the many approaches, the DNA microarray 
technology will be the application field of this research.
Medical  and  biologist  experts  have  a  lot  of  genomic 
(based  on  DNA  microarray)  and  clinical  information  of 
patients with any disease.  Even more,  they have available 
different published gene profiles (biomarkers) for diseases as 
Breast Cancer. However, for them is very difficult to analyze 
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all  this  information  and  obtain  any conclusion  in  a  short 
time. Visualization techniques have been of great assistance 
to experts in different fields of research. These techniques 
allow to  bring  out  the  real  important  data  characteristics, 
arising the possibility of constructing VR spaces to visually 
understand the intrinsic nature of data in a very short time. 
Although  some techniques  as  PCA (Principal  Component 
Analysis)  [1]  have  been  used  in  genomic  field  to  see 
relationship between genes, these are not frequently used to 
obtain patterns and conclusions of any gene in any disease. 
That  is  because  the  representation  in  3D transforms gene 
features  in  3  new  values  (xi,yi,zi),  but  this  with  the 
transformation  we have  lost  its  scientific  significance  and 
there is not any possibility of reverse the transformation.
However, trying to obtain a representation that allows us 
to  see  the  behavior  of  all  gene  features  as  well  as  the 
possibility  of  real  interaction  with  experts.  A  novel 
framework, called VR BioViewer, is presented in this paper, 
applying it to Van’t  Veer breast  cancer  dataset.  With this, 
medical experts from La Paz Hospital (Madrid) can visualize 
patients as points in a VR space, gene features as different 
axis  represented  in  3D,  and  can  interact  with  the  model: 
moving any gene axis (f. e.  two genes are related, thus their 
axis have to be closed), seeing gene information of other past 
researches  (using  literature),  or  clinical  information  of 
patients by clicking in any point.
The  structure  of  the  paper  is  as  follows:  Next  section 
presents  DNA  microarray  technology.  Section  3  analyzes 
briefly  a  state  of  art  about  Visualization  and  the  use  of 
optimization  in  visualization.  Section  4  describes  the  VR 
BioViewer framework. Finally, conclusions, future lines and 
acknowledgments are presented in the last sections.
II. DNA MICROARRAY
DNA  microarrays  [2,3,4,5]  are  a  relatively  new  and 
complex  technology  used  in  molecular  biology  and 
medicine.  Microarrays  present  unique  opportunities  in 
analyzing  gene  expression  and  regulation  in  an  overall 
cellular context. This technology has been applied in diverse 
areas ranging from genetic and drug discovery to disciplines 
such as virology, microbiology, immunology, endocrinology 
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and neurobiology. Microarray technology is the most widely 
used  technology  for  the  large-scale  analysis  of  gene 
expression  because  it  provides  a  simultaneous  study  of 
thousands of genes by single experiment.
A  DNA  microarray  consists  of  an  arrayed  series  of 
thousands  of  microscopic  spots  of  DNA  oligonucleotides 
(shorts  molecules  consisting of  several  linked  nucleotides, 
between  10  and  60,  chained  together  and  attached  by 
covalent  bonds),  called  Expressed  Sequence  Tags  (ESTs), 
each  containing  several  molecules  of  a  specific  DNA 
sequence. This can be a short section of a gene or other DNA 
element.
There are several biological steps [6, 7] in the design and 
implementation  of  a  DNA  microarray  experiment:  Probe, 
Chip  Manufacture,  Sample  preparation,  Assay 
(Hibridization [6]), Readout and Informatics.
Fig. 1.  Biological process of DNA Microarray analysis. Image from Gibson 
& Muse 2002
A. Breast Cancer dataset
The  Van’t  Veer  dataset  [8]  on Breast  Cancer  has  been 
considered to use in this research. Van’t Veer results have 
been approved by the FDA (Food and Drug Administration) 
and  were  applied  in  a  genomic  profiling  test,  called 
MammaPrint, that predicts whether patients will suffer breast 
cancer relapse or not. The data is divided into two groups, 
learning and validation instances. The training data consist 
of  78  patients,  34  of  whom  are  patients  that  developed 
distance metastases within 5 years (poor prognosis). The rest 
of  the  dataset  (44  patients)  are  the  ones  who  remained 
healthy from the disease after their initial diagnosis for an 
interval of 5 years (good prognosis).  The second group of 
patients  (validation  dataset)  consists  of  19  patients,  12 
patients  with  poor  prognosis  and  7  with  good  prognosis. 
DNA microarray analysis was used to determine the mRNA 
expression  levels  of  approximately 24,500  genes  for  each 
patient. All the tumors were hybridized against a reference 
pool  made  by pooling  equal  amounts  of  RNA from each 
patient.
• Preprocessing: Obviously  real  data  have  a  lot  of 
redundancy,  as  well  as  incorrect  or  missing values, 
depending on some factors. So, as first step, we carry 
out  some  pre-processing  in  order  to  clean  up  and 
prepare the data. We also discard variables with low 
internal  variance  or  low  Pearson  correlation  with 
outcome.
Several  pre-processing algorithms have been carried 
out  through  the  training  data.  Firstly,  we  have 
discarded  genes  that  are  replicated.  Next,  we have 
discarded patients that had more than 80% of missing 
gene  values.  All  data  have  been  background 
corrected,  normalized  and  log-transformed  using 
Lowess  Normalization  [9].  Missing  values  were 
estimated  using  a  15-weighted  nearest  neighbor 
algorithm [10] (kNN Impute).
• Biomarker selection:  The objective of this paper is 
not  to  obtain  a  feature  selection  of  24,500  genes 
expressions, but to create a model that represents this 
data efficiently. Thus, the microarray data is filtered 
to the 70 Van’t Veer [8] selected genes (accepted by 
the FDA as breast cancer biomarkers), and these are 
the  features  we  will  use  to  represent  the  data  in 
BioViewer.
III. OPTIMIZATION AND VISUALIZATION 
The  role  of  visualization  techniques  in  the  knowledge 
discovery process (KDD) [28] is well known. The increasing 
complexity of  the data  analysis  procedures  makes it  more 
difficult for the user to extract useful information out of the 
results generated by the various techniques. So, a graphical 
representation  is  appealing  from the  point  of  view of  the 
user.  Besides,  if  this  visualization  is  complemented  with 
elements coming from a VR space,  such as interaction or 
immersion in real time, we obtain a suitable framework for 
visualizing high dimensional data. The creation of VR spaces 
for  visualizing  high-dimensional  dataset  means  a  bigger 
insight  of  the  underlying  patterns  or  trends  in  data.  To 
achieve that, we try to visually stimulate the human skills of 
understanding  the  intrinsic  nature  of  data.  The  key  is 
interaction. Interacting with 3D representations allow us to 
observe, for example, how clustered data is or the variation 
over time. These features make VR a much more intuitive 
environment  than  traditional  ones  for  representing  high 
dimensional data.
In  many cases,  the  input  data  of  these  representations 
come directly from optimization techniques [27]. There are 
several  examples  that  have  been  previously  reported  in 
[11,12,13].  Here,  a  multi-objective (MOO) optimization is 
used to the visualization of high dimensional datasets (i.e. 
leukemia or  lung cancer).  MOO optimization  [26]  studies 
optimization  problems  involving  more  than  one  objective 
function  and  the  goal  is  to  find  one  or  more  optimal 
solutions. It is very common to use evolutionary algorithms 
for solving MOO problems (MOEA in general and MOGA if 
based on genetic algorithms). An evolutionary algorithm has 
four different  steps:  initialization,  mutation,  recombination 
and selection. 
• Initialization: This initial phase focuses on select a 
population randomly. 
• Mutation: the idea is to create a new individual v, 
for  each  one  of  the  population  xi.  To  make  it 
possible  we  need  to  select  three  different 
individuals of the population (r1, r2, r3). Where ri 
has to be different and no one can be the parent. 
Consider that, F is a parameter in the interval [0, 2]. 
• Recombination:  this  operator  generates  the 
crossover between the element of the population xi 
and  the  new  individual  generated,  v. 
Implementation is made based  on the exponential 
criteria. 
• Selection:  each  element  has  a  metric  to  evaluate 
how good  or  bad  is  the individual,  this metric  is 
called  fitness.  Comparing  the  new  element 
generated v and the selected xi, the algorithm select 
the one which has the best fitness. 
Several  multi-objective  optimization  algorithms inspired 
by this principles have been proposed. Among them, VEGA 
[14], HLGA [15], NSGA, NSGA-II [16,17,18], SPEA [19] 
and many others. In any case, a MOO optimization is out of 
scope  in  this  study.  Instead,  an  optimization  technique 
involving  two  different  available  objective  functions  is 
carried out, particularly a differential evolution algorithm.
Handling large amounts of data arises a problem known as 
'curse  of  dimensionality'.  The  high  dimensional  nature  of 
genomic datasets makes difficult a straightforward analysis. 
So, it requires using several techniques for overcoming these 
problems.  Dimensionality reduction is the transformation of 
high-dimensional  data  into  a  meaningful  representation  of 
reduced dimensionality.  Ideally,  the reduced representation 
has  a  dimensionality  that  corresponds  to  the  intrinsic 
dimensionality of  the data.  The intrinsic  dimensionality of 
data  is  the  minimum  number  of  parameters  needed  to 
account  for  the  observed  properties  of  the  data. 
Dimensionality reduction is important in many fields, since it 
facilitates  visualization,  classification  and  compression  of 
high-dimensional  data,  by  mitigating  the  curse  of 
dimensionality  and  other  undesired  properties  of  high-
dimensional spaces [20].  Among this techniques,  there are 
also another that accomplish a transformation of the involved 
features (transformation-based dimensionality reduction) i.e. 
'Star  Coordinates'  algorithm  [21].  It  constructs  a  low 
dimensional space composed of a linear combination of the 
attributes.
IV. VR BIOVIEWER
Here, VR BioViewer framework is presented. We divide 
it  into  two  basic  modules.  The  first  one  deals  with  the 
optimization part  and the second one is for visualizing the 
results produced after the optimization. So, we are going to 
explain both methods in order to get a clear understanding of 
the pipeline of the process pipeline.
A. Optimization
Seeing the optimization module as a black box model (fig. 
2),  we can consider  that  the input  is  the n-dimensionality 
data and the output is the best distribution of the axes. That 
is, the distribution that better preserves the intrinsic geometry 
of  n-dimensional  data,  after  a  representation  using  star 
coordinates algorithm.
Fig.2. Optimization process of the axis
To set  up the optimization module we implemented the 
differential evolution. The population of our model is the set 
of  the  different  spatial  distribution  of  the  axes,  and  the 
initialization is done in a randomly way. So, the optimization 
tries to  find the best  configuration of the axis in order  to 
preserve,  as  possible  ,  the  geometry of  the  n-dimensional 
data.  Note that each axis corresponds to each one  of the 
attributes in the input  data,  and  has  three  components 
normalized in spherical  coordinates (t, p, r) where  r is the 
radius,  p is the azimuthal angle in the interval [0,  π] and  t 
corresponds to the polar angle, interval [0, 2π]. In fact, we 
have to transform this problem to the cartesian coordinates to 
evaluate  de  distances.  In  the  following  formula,  the 
transformation between spherical  and cartesian coordinates 
is shown.
At the beginning, the model has to calculate pair to pair 
distances of all  the instances in the initial  data.  So this is 
stored in a matrix that is considered as the  target distance  
matrix,  and it is squared.  In  other words,  it  represents the 
distance  between  the  instance  i-th in  the  rows  and  the 
instance j-th in the columns.
In the study,  the Manhattan distance metric (L1 norm) is 
considered because is consistently more preferable than the 
{x=r sin tcos py=r sin t sin  pz=r cos  t }
Euclidean distance metric  (L2 norm) for  high dimensional 
data mining applications [22].
So, the aim is to preserve the distance of the data with 
high dimensionality and resemble the low dimensional data. 
As consequence of this, the model extracts the geometry of 
the  initial  data  and  this  geometry is  mapped into the  low 
dimensionality data.
Before calculating the fitness, it is needed a representation 
of the data with the optimized axes,  by means of the star 
coordinates algorithm. Then, the  generated distance matrix 
is  obtained and it  represents  the distances  between all  the 
instances  of  the  data  using  these  new  optimizated  axes. 
Needless  to  say,  that  this  algorithm  makes  a  linear 
combination of all the axes, or attributes, of the data.
Finally,  the  generated  matrix and the  target  matrix are 
compared. To establish the comparison between two rows of 
those matrixes we implemented the Pearson correlation. To 
get a value of the fitness there are to methods: (1) based on 
the mean of the correlations and (2) based on a threshold. In 
the  first  option  all  the  correlations  between same rows in 
both matrixes are computed, and have a arithmetic mean of 
them. In  the second one, however,  all  the correlations are 
obtained and for each one a threshold is evaluated to each of 
them, so then one vote is counted. Lastly, all the votes are 
added up and the result is divided between the number of 
instances.
B. Visualization
Once the optimization module has produced the results, 
the aim is just to obtain a 3D representation of the data in 
order to study in detail possible patterns, trends or outliers in 
the dataset as well as separation of classes, if it is possible.  
The input data of the visualization module consist of the set 
of optimized axes that will make possible a successful 3D 
embedding  of  the  intrinsic  geometric  structure of  the  n-
dimensional manifold. This results in a structure preservation 
with a minimum information loss, depending on the quality 
of the optimization process.
 A visualization tool, 'Unity3D' [23], is used. Unity3D is a 
game  engine  designed  for  the  creation  of  multiple  3D 
powerful interactive contents. The implemented visualization 
algorithm takes the output data of the optimization module as 
input data, and generates a 3D representation of the original 
n-dimensional dataset according to the optimized axes. The 
background of this dimensionality transformation is the star 
coordinates  algorithm.  The  original  algorithm  works  as 
follows.  First,  it  considers  the  attributes  of  the  dataset  as 
coordinate axes. Then it arranges the coordinate axes onto a 
flat  (two-dimensional)  surface  forming  equidistant  angles 
between axes. The mapping of an n-dimensional point to a 
two-dimensional cartesian coordinate is computed by means 
of the sum of all unit vectors of every coordinate, multiplied 
by the data value of that coordinate. In this framework a 3D 
mapping is used, so it can be described as the next formula:
Where  dji is the  j-th data with the i-th  value, mini  is the 
minimum value of the scaled values in every coordinate, uxi 
and uyi are unit vectors in the direction of every coordinate, 
and ox,oy,oz is the origin of the coordinate system. Figure 3 
illustrates an example of the final position of a data point in a 
8-dimensional  dataset  (the  example  is  2D  but  easily 
extensible to 3D by dimensional analogy).
Fig.  3.   Process of obtaining  the final  position  of a  data  point  for a 8-
dimensional dataset (two-dimensional space).
 Once  the  representation  is  done,  the  fundamental 
objective is that the expert oncologist classify, in a visually 
way,  the  breast  dataset  by  a  representation  with  colored 
spheres according to the class (black: relapse (R); gray: non-
relapse  (N.R)  in  breast  cancer  disease).  It  would  be  very 
useful if the oncologist could establish any kind of relations 
or  connections  between  patients  or  genes,  so  a  new 
mechanism  of  interaction  based  on  the  variation  of  the 
positions of the axes is provided. This variation will generate 
in  real  time  a  new  spatial  distribution  of  the  spheres. 
Interacting  with  the  coordinate  axis  could  provide  us 
valuable information. There might be many observations the 
expert might be interested in. 
P j x , y , z =ox∑i=1
n
uxi d ji−mini ,
oy∑
i=1
n
u yid ji−mini ,
o z∑
i=1
n
u zi d ji−mini

Fig.  4.   Final visualization  after the optimization  process.  Black spheres 
represent  patients  who suffered a  relapse  in  breast  cancer  disease.  Gray 
spheres  represent  healthy  patients  who  do  not  relapse.  Dotted  lines 
represent coordinate axes (genes). A separation of classes is clearly visible.  
Last, the dotted square shows healthy patients in the relapse side.
The first one is related with clustering. Just looking at the 
distribution of data points. Playing with the coordinate axes, 
scaling or rotating. Finally one must see how spheres move 
in and out of clusters.  The second one is correlation. The 
idea  is  the  same,  the  oncologist  could  interact  with  the 
coordinate axes, multiple of them at the same time, scale a 
number of them at the same time, and observe how spheres 
move. He also has the possibility of turn on tracking so that 
consecutive movements of  a  data  point  are  represented as 
lines so he can better observe where spheres go. Then  he 
can examine, the direction points go, that tells you how the 
genes are correlated.  It  is important  to mention that  every 
operation above described must be supported by the expert's 
opinion  in  order  to  achieve  valid  and  useful  conclusions. 
Thus, a new tool that could make easier the acquisition of 
knowledge from medical data is provided. 
Fig.  5.   Final visualization  after the optimization  process.  No coordinate 
axes.
Fig. 4 and 5  shows a clear separation of the two classes. 
A possible interpretation is that in a n-dimensional space, the 
intrinsic nature of data makes evident a real division between 
patients who have relapsed and non-relapsed in breast cancer 
disease.  After  all,  a  three-dimensional  embedding  of  the 
data's  intrinsic  geometric  structure  is  mapped  from  the 
original n-dimensional space, what it means that the original 
geometry is being approximated. 
If the results are analyzed with more detail, it is noticeable 
that several gray spheres lie on the black side. In fact, if the 
optimization process is continually repeated, in all cases the 
same representation is obtained. Moreover, always the same 
N.R  patients  lie  on  the  black  side.  This  fact  could  be 
exclusively  seen  from a  medical  point  of  view and  it  is 
possible that it has a major importance. For example, a priori 
patients with similar values for attributes must be grouped 
together but, why always the same N.R patients lie on the 
black side if the are supposed to be on the gray one? What 
does it means? Maybe, a valid interpretation could be that 
these patients consumed a certain kind of medicine during 
the chemotherapy process, so they didn't suffer a relapse. In 
this case, the next step could be to identify this medicine and 
the biomarkers, with the help of an expert. 
Finally,  the  knowledge  acquisition  process  is 
complemented  with  a  strong  interaction  component.  The 
expert  also  has  the  possibility  of  interacting  with  the 
application by means of rotating, scaling, or deleting axes in 
real time (fig.6). An optimal tradeoff between graphic quality 
and performance has been achieved. The expert can navigate 
and  become absorbed  into  the  environment  thanks  to  the 
head tracking system. It works in the following way: just by 
using a standard webcam and FaceAPI software [24].  The 
visualization  algorithm  recognizes  the  data  stream, 
previously  filtered  by  FaceAPI  software,  and  makes  a 
mapping of the head movements to the main camera.
Fig. 6.  Interacting with the coordinate axes. The dotted square shows a 
selected gen , 'NM_014791'.
C. Results
Here, final results have been separated into two categories 
depending on the objective function used in the optimization 
process.  The first  one represents the method based on the 
mean of the correlations, and the second one is based on the 
threshold method. 
Table  1  shows  the  experimental  settings  in  the 
optimization process.
Parameters Experimental values
Number of generations 15000
Population size 50
Crossover probability 0.7
Mutation factor 0.5
Distance Metric Manhattan (L1 norm)
Table 1.  Experimental settings for computing the set of optimized axes.
Different parameters are shown. For example, the number 
of  generations  or  the  size  of  the  initial  population  in 
differential  evolution  algorithm.  We can  also  observe  the 
crossover probability (C.P) and the mutation factor (M.F). 
Regarding to  the distance  metric,  a  Manhattan distance  is 
used. 
Fig. 7.  Evolution of the fitness value using different threshold values. 
Threshold method.
Different  fitness  values  are  obtained  according  to  the 
threshold value we use (fig. 7). For example, using a near 1 
threshold will cause obtaining a small fitness value.  For  a 
0.95 value, the explanation is that we are voting only if the 
correlation  between  the  same  row  in  target  matrix and 
generated  matrix is  greater  or  equal  than  0.95.  The  final 
fitness value for a 0.95 threshold is 0.572917, it means that 
the  57.2917%  of  individuals  in  the  population  (55  of  96 
patients) are correlated each other with a threshold greater or 
equal than 0.95.  Nevertheless,  if  a 0.80 threshold value is 
used,  the 0.947917 fitness  value is  obtained,  so 91  of  96 
patients are correlated with a threshold greater or equal than 
0.80.  These high correlations between pair  of distances in 
both matrixes (target and  generated by optimization) show 
that it is necessary to find a tradeoff between the final fitness 
value and the geometry preservation in data visualization. 
Fig.  8.   Evolution  of  the  fitness  value  for  different  threshold  values. 
Method based on the mean of the correlations.
Figure 8 illustrates the method based on the mean of the 
correlations.  It  is simpler than the previous one. Here,  the 
main  benefit  of  this  method  is  that  a  more  uniform 
convergence is obtained.  In  consequence,  the fitness value 
for  every  individual  of  the  population  is  being  fitted 
gradually.  Instead,  the  drawback  is  that  it  penalizes  high 
correlations and gives more importance to low correlations, 
because of the arithmetic mean. 
V. CONCLUSIONS AND FUTURE LINES
This paper presented a new VR framework for visualizing 
and  interacting  with  high  dimensional  DNA  microarray 
datasets. The development is supported by an optimization 
process. It tries to find an optimal solution to preserving the 
intrinsic geometric structure of the n-dimensional manifold 
where the original dataset is embedded.
Taking into account the biological nature of data and the 
limitations for a computer engineer in terms of understanding 
and  interpreting  the  data  visualization,  it  is  necessary  to 
complement  the  final  results  with  the  experience  of  a 
specialist. For that reason, it is needed a close collaboration 
with the expert in order to validate appropriately the results.  
Due to the medical nature of data and considering they are 
labeled, a direct approach based on supervised classification 
is  carried  out.  The  axes  optimization  process  is  done 
independently of the data class, so the same concept could be 
applied  to  different fields,  for  example in semi-supervised 
classification or unsupervised classification. In other words, 
the  underlying  idea  is  based  on  the  possibility  of 
extrapolating this development to any dataset that requires a 
visual and interactive representation. 
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It  could  be  useful  to  use  VR  BioViewer  to  get  better 
insight into prediction issues, particularly survival analysis in 
cancer. Using different data sources, for example the patient 
clinical  information  and  the  medicines  used  during  the 
treatment, a complete visual study about who are alive for a 
given  period  could  be  done.   Another  possibility  is  to 
identify the biomarkers and add additional information about 
them,  or  giving  them  more  intensity  in  the  final 
representation.
Regarding to  the distance  metric  used  to  get  a  suitable 
geometry  preservation,  it  is  considered  that  the  use  of 
geodesic  distances  over  the  neighborhood  graph  could 
improve the manifold learning [25]. It will be considered for 
next revisions. 
These  are  preliminary  results  for  which  further 
experimentation would be required and they show a potential
for advising and supporting the criterion of the oncologist 
expert.
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